Mizusawa H, Lee C H, Kakefuda T
Mutat Res. 1981 Jun;82(1):47-57. doi: 10.1016/0027-5107(81)90137-8.
Plasmid-mediated transformation and mutagenesis induced by (+/-)-trans-benzo[alpha]pyrene-7,8-dihydrodiol-9,10-oxide (BP-DEI) in recipient Escherichia coli (E. coli) have been studied. Because plasmid DNA is used, the system is entirely free from direct toxic effects of BP-DEI on the recipient cells. Plasmid pK0482 DNA, which has two dominant genes, beta-lactamase (amp-r) and galactokinase (galK) was modified with BP-DEI prior to its transformation of E. coli N99, AB1157, AB2463(recA-) and AB1886(uvrA-). Transformants were selected by ampicillin resistance and mutations were analyzed simultaneously by the altered expression of the galK gene. (1) Approx. 3 molecules of BP-DEI per molecule of pK0482 DNA decreased the transformation efficiency to 37% in AB1157 and the mutation frequency in this strain was proportional to the amount of BP-DEI covalently bound to pK0482 DNA. (2) In Ab1886(uvrA-) a 37% transformation efficiency was produced by only 1 molecule of BP-DEI per molecule of pK0482 DNA, and the mutation frequency in this strain was higher than in AB1157. (3) In AB2463(recA-), the transformation efficiency was similar to that obtained with AB1157, but mutagenesis was clearly suppressed. (4) Polyacrylamide gel patterns of restriction digests of the pK0482 mutated at the galK gene were indistinguishable from those of the unmutated plasmid DNA.
已对(±)-反式苯并[a]芘-7,8-二氢二醇-9,10-环氧化物(BP-DEI)在受体大肠杆菌(E. coli)中诱导的质粒介导的转化和诱变进行了研究。由于使用的是质粒DNA,该系统完全不受BP-DEI对受体细胞的直接毒性影响。具有两个显性基因β-内酰胺酶(amp-r)和半乳糖激酶(galK)的质粒pK0482 DNA在转化大肠杆菌N99、AB1157、AB2463(recA-)和AB1886(uvrA-)之前用BP-DEI进行了修饰。通过氨苄青霉素抗性筛选转化体,并通过galK基因表达的改变同时分析突变情况。(1)每分子pK0482 DNA约3个BP-DEI分子使AB1157中的转化效率降至37%,该菌株中的突变频率与共价结合到pK0482 DNA上的BP-DEI量成正比。(2)在Ab1886(uvrA-)中,每分子pK0482 DNA仅1个BP-DEI分子就能产生37%的转化效率,且该菌株中的突变频率高于AB1157。(3)在AB2463(recA-)中,转化效率与AB1157相似,但诱变明显受到抑制。(4)在galK基因处发生突变的pK0482的限制性消化产物的聚丙烯酰胺凝胶图谱与未突变的质粒DNA的图谱无法区分。